SPUTUM CULTURE AND POLYMERASE CHAIN REACTION TESTS FOR IDENTIFICATION OF BACTERIAL PATHOGENS IN EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

  • Muhammad Noman Rashid Department of Physiology, Shaheed Mohtarma Benazir Bhutto Medical College, Karachi, Pakistan
  • Zulfiqar Laghari Department of Physiology, University of Sindh, Jamshoro, Pakistan
  • Lubna Riaz Department of Forensic Medicine, Dow University of Health Sciences, Karachi, Pakistan
  • Beenish Noman Department of Obs/Gyn, The Aga Khan University Hospital, Karachi, Pakistan
  • Rasheed Ahmed Khan Department of Pulmonology, Shaukat Khanum Memorial Hospital and Research Centre, Lahore, Pakistan
  • Ali Muhammad Soomro Department of Physiology, University of Sindh, Jamshoro, Pakistan
Keywords: Chronic Obstructive Pulmonary Disease, COPD, Haemophilus, Moraxella, Nocardia, Legionella, Bifidobacter

Abstract

Background: Chronic Obstructive Pulmonary Disease (COPD) is a growing pulmonary disorder comprised of chronic bronchitis and emphysema. This condition is characterized by breathlessness, decrease immunity, and recurrent respiratory tract infections (RTI). The objective of this study was identification of predominant bacterial pathogens in respiratory tract, responsible for acute exacerbation of chronic obstructive pulmonary disease (COPD) patients using highly sensitive real-time Polymerase Chain Reaction (PCR) and conventional methods. Methods: The retrospective study was conducted in tertiary care hospitals of Karachi, 120 diagnosed regular follow-ups of chronic obstructive pulmonary disease (COPD) patients with informed and written consent aged between 40–55 years from both sexes were included in the study. All samples were analyzed through sputum culturing and PCR assays. Results: Sixty stable state samples and 60 aggravated condition samples were collected from subjects on treatment for the chronic obstructive pulmonary disease (COPD). Stable state samples were negative for Chlamydophila pneumonia, and Mycoplasma pneumonia. However, samples showed the presence of Moraxella, Streptococcus, Nocardia, Lactobacilli, and Legionella. In aggravated state samples Haemophilus influenza, Staphylococcus aureus, Staphylococcus pneumonia, E. coli, Lactobacillus, Bifidobacteria, and Nocardia were observed. Conclusion: The current findings suggest that there is a unique relationship between bacterial pathogens and the recurrence of the severity of symptoms in COPD. To understand the diversity of atypical and typical microbiota it is important to utilize sensitive advanced techniques for routine investigations of the COPD population.

Pak J Physiol 2022;18(1):39–43

References

Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187(4):347–65.

Rycroft CE, Heyes A, Lanza L, Becker K. Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis 2012;7:457–94.

Viegi G, Maio S, Fasola S, Baldacci S. Global Burden of Chronic Respiratory Diseases. J Aerosol Med Pulm Drug Deliv 2020;33(4):171–7.

Nakou A, Papaparaskevas J, Diamantea F, Skarmoutsou N, Polychronopoulos V, Tsakris A. A prospective study on bacterial and atypical etiology of acute exacerbation in chronic obstructive pulmonary disease. Future Microbiol 2014;9(11):1251–60.

Miravitlles M, Anzueto A. Role of infection in exacerbations of chronic obstructive pulmonary disease. Curr Opin Pulm Med 2015;21(3):278–83.

Santos S, Marin A, Serra-Batlles J, de la Rosa D, Solanes I, Pomares X, et al. Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation. Int J Chron Obstruct Pulmon Dis 2016;11:515–25.

Jung CY, Choe YH, Lee SY, Kim WJ, Lee JD, Ra SW, et al. Use of serology and polymerase chain reaction to detect atypical respiratory pathogens during acute exacerbation of chronic obstructive pulmonary disease. Korean J Intern Med 2018;33(5):941–51.

Shimizu K, Yoshii Y, Morozumi M, Chiba N, Ubukata K, Uruga H, et al. Pathogens in COPD exacerbations identified by comprehensive real-time PCR plus older methods. Int J Chron Obstruct Pulmon Dis 2015;10:2009–16.

Todea DA, Postolache P, Herescu AC, Rosca LE, Coman AC. Relation between bacterial infections, exacerbations, and quality of life in COPD. Chest 2013;144(4):728A.

Bafadhel M, Haldar K, Barker B, Patel H, Mistry V, Barer MR, et al. Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function. Int J Chron Obstruct Pulmon Dis 2015;10:1075–83.

Aydemir Y, Aydemir Ö, Kalem F. Relationship between the GOLD combined COPD assessment staging system and bacterial isolation. Int J Chron Obstruct Pulmon Dis 2014;9:1045–51.

Haldar K, Bafadhel M, Lau K, Berg A, Kwambana B, Kebadze T, et al. Microbiome balance in sputum determined by PCR stratifies COPD exacerbations and shows potential for selective use of antibiotics. PLoS One 2017;12(8):e0182833.

Perotin JM, Dury S, Renois F, Deslee G, Wolak A, Duval V, et al. Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a pilot prospective study. J Med Virol 2013;85(5):866–73.

Margalit I, Goldberg E, Ben Ari Y, Ben-Zvi H, Shostak Y, Krause I, et al. Clinical correlates of nocardiosis. Sci Rep 2020;10(1):14272.

Garcia-Bellmunt L, Sibila O, Solanes I, Sanchez-Reus F, Plaza V. Pulmonary nocardiosis in patients with COPD: characteristics and prognostic factors. Arch Bronconeumol 2012;48(8):280–5.

Margalit I, Goldberg E, Ben Ari Y, Ben-Zvi H, Shostak Y, Krause I, et al. Clinical correlates of nocardiosis. Sci Rep 2020;10(1):14272.

Sethi S. Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon? Proc Am Thorac Soc 2004;1(2):109–14.

Finney LJ, Ritchie A, Pollard E, Johnston SL, Mallia P. Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzae. Int J Chron Obstruct Pulmon Dis 2014;9:1119–32.

Monsó E, Ruiz J, Rosell A, Manterola J, Fiz J, Morera J, et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995;152(4 Pt 1):1316–20.

Sethi S, Sethi R, Eschberger K, Lobbins P, Cai X, Grant BJ, et al. Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;176(4):356–61.

Sze MA, Dimitriu PA, Hayashi S, Elliott WM, McDonough JE, Gosselink JV, et al. The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;185(10):1073–80.

Varmaghani M, Dehghani M, Heidari E, Sharifi F, Moghaddam SS, Farzadfar F. Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis. East Mediterr Health J 2019;25(1):47–57.

Jaganath D, Miranda JJ, Gilman RH, Wise RA, Diette GB, Miele CH, Bernabe-Ortiz A, Checkley W; CRONICAS Cohort Study Group. Prevalence of chronic obstructive pulmonary disease and variation in risk factors across four geographically diverse resource-limited settings in Peru. Respir Res 2015;16(1):40.

Llor C, Moragas A, Hernández S, Bayona C, Miravitlles M. Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;186(8):716–23.

Downloads

Download data is not yet available.
Published
2022-03-31
How to Cite
1.
Rashid M, Laghari Z, Riaz L, Noman B, Khan R, Soomro A. SPUTUM CULTURE AND POLYMERASE CHAIN REACTION TESTS FOR IDENTIFICATION OF BACTERIAL PATHOGENS IN EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. PJP [Internet]. 31Mar.2022 [cited 4Jul.2022];18(1):39-3. Available from: https://pjp.pps.org.pk/index.php/PJP/article/view/1005